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Abstract
Background: Restriction/modification systems provide the dual function of protecting host DNA against
restriction by methylation of appropriate bases within their recognition sequences, and restriction of
foreign invading un-methylated DNA, such as promiscuous plasmids or infecting bacteriphage. The
plasmid-encoded LlaJI restriction/modification system from Lactococcus lactis recognizes an asymmetric,
complementary DNA sequence, consisting of 5'GACGC'3 in one strand and 5'GCGTC'3 in the other and
provides a prodigious barrier to bacteriophage infection. LlaJI is comprised of four similarly oriented genes,
encoding two 5mC-MTases (M1.LlaJI and M2.LlaJI) and two subunits responsible for restriction activity
(R1.LlaJI and R2.LlaJI). Here we employ a detailed genetic analysis of the LlaJI restriction determinants in
an attempt to characterize mechanistic features of this unusual hetero-oligomeric endonuclease.
Results: Detailed bioinformatics analysis confirmed the presence of a conserved GTP binding and
hydrolysis domain within the C-terminal half of the R1.LlaJI amino acid sequence whilst the N-terminal half
appeared to be entirely unique. This domain architecture was homologous with that of the "B" subunit of
the GTP-dependent, methyl-specific McrBC endonuclease from E.coli K-12. R1.LlaJI did not appear to
contain a catalytic centre, whereas this conserved motif; PD....D/EXK, was clearly identified within the
amino acid sequence for R2.LlaJI. Both R1.LlaJI and R2.LlaJI were found to be absolutely required for
detectable LlaJI activity in vivo. The LlaJI restriction subunits were purified and examined in vitro, which
allowed the assignment of R1.LlaJI as the sole specificity determining subunit, whilst R2.LlaJI is believed to
mediate DNA cleavage.
Conclusion: The hetero-subunit structure of LlaJI, wherein one subunit mediates DNA binding whilst the
other subunit is predicted to catalyze strand hydrolysis distinguishes LlaJI from previously characterized
restriction-modification systems. Furthermore, this distinction is accentuated by the fact that whilst LlaJI
behaves as a conventional Type IIA system in vivo, in that it restricts un-methylated DNA, it resembles the
Type IV McrBC endonuclease, an enzyme specific for methylated DNA. A number of similar restriction
determinants were identified in the database and it is likely LlaJI together with these homologous systems,
comprise a new subtype of the Type II class incorporating features of Type II and Type IV systems.
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Background
The diverse structural and functional activities described
for restriction endonucleases (REases) is reflected by their
ubiquitous abundance among prokaryotic organisms [7].
These enzymes are typically components of restriction/
modification (R/M) systems where they primarily serve as
defensive instruments against bacteriophage infection
and other invading "foreign" DNA.
Four distinct groups of REases are known, with the "Type
II" group being the most richly represented [8]. Members
of this group, of which there are eleven subtypes, generally
recognize relatively short DNA sequences and specifically
cut within or reasonably close to such sequences in a Mg+2
dependent manner.
Although generally lacking significant amino acid
sequence homology, structural analysis of many of these
REases has revealed in some instances a conserved core,
consisting of a four/five-stranded mixed β-sheet flanked
by α-helices, reviewed in [9]. This core spatially localizes
two carboxylates (present in the amino acids D and D/E)
which are believed to be involved in divalent metal ion
binding, and a lysine residue, possibly involved in posi-
tioning and/or activation of an attacking nucleophile
[10]. Together it is believed that these residues comprise
the REase catalytic site, the PD...D/EXK motif, responsible
for phosphodiester bond hydrolysis in the target DNA
molecule.
For double-stranded scission this hydrolysis event must
occur on both strands of the target DNA thereby requiring
two catalytic sites [11], although single-site exceptions do
exist [12,13]. Consequently, the active forms of many
Type II REases are homodimers (or even tetramers), with
each identical subunit providing a single catalytic site for
individual strand hydrolysis [9,14]. Of course given the
multifarious nature of the Type II group, it is not surpris-
ing that unusual hetero-multimeric REases, comprised of
unique subunits, consisting of the associated products of
different genes, have been described [1,3,15-18].
One such characterized enzyme, BbvCI, has been shown
to be heterodimeric, with each individual subunit inde-
pendently responsible for cleavage of separate strands of
its asymmetric recognition sequence [15,19]. Similarly,
the Bpu10I REase requires two different subunits for its
activity however, in this instance, a direct interaction
between the subunits has yet to be completely established
[17].
Previously we have described the cloning and transcrip-
tional regulation of LlaJI R/M system [1,20]. The LlaJI
gene cluster, encoded by the lactococcal plasmid pNP40,
consists of two 5mC MTase-encoding genes followed by
two REase-encoding genes which mediate a prodigious
barrier to bacteriophage infection [1]. The specificity of
the system was determined to be asymmetric but comple-
mentary, comprised of 5'GACGC'3 in one strand and
5'GCGTC'3 in the other [20]. Perhaps the most striking
feature of this R/M system is its homology to the methyl-
specific REase McrBC. This highly unusual enzyme, which
lacks an associated MTase, has been characterized exten-
sively [10,21-31]. Its orphan nature, unusual specificity
and cofactor requirements define McrBC, together with its
identified homologues, as a distinct REase group [8].
The mcrBC locus encodes two major products, McrB (53
kDa) and McrC (39 kDa), which mediate the restriction
phenotype [26]. McrBC recognizes two methylated/hemi-
methylated RmC sites (separated by 40 bp to up to 3000
bp) and cleaves at random positions between the two
[24,25,32]. The optimal stoichiometry for cleavage in vitro
has been suggested as 3–5:1, McrB:McrC (although a 1:1
ratio has been reported by another group [10]), with the
cleavage reaction strictly dependent upon GTP and Mg+2
[25,33].
The McrB subunit harbours the specific DNA binding
activity (which resides within its N-terminus), in addition
to GTP binding and hydrolysis activities [22,30,34]. The
McrC subunit contains the catalytic centre for cleavage
[10]. Following binding to its methylated target site,
McrBC facilitates a GTP-dependent translocation of the
DNA, akin to the mechanisms of other NTP-dependent
REases of the Type I and III groups, with cleavage ensuing
upon stalling of the translocating complex [23,35]. Fur-
thermore, it has been shown that McrB forms high molec-
ular weight complexes – heptameric rings, in the presence
of GTP (although independent of GTP hydrolysis). These
complexes can further multimerise to tetradecamers,
structures stabilized by the binding of McrC – which con-
stitutes the "active" form of the endonuclease [31].
In this report, we execute a detailed genetic and pheno-
typic assessment of the McrBC-like LlaJI endonuclease
which serves to portray the complexity of this unique
enzyme.
Results
Sequence analysis of LlaJI
R1.LlaJI is predicted to be a 67.2 kDa protein which exhib-
its sequence homology to a number of partially character-
ized and putative REases in the database (see Figure 1A
and 1B). These homologies primarily correspond to a
region proposed to represent a domain responsible for
GTP binding and hydrolysis (Fig 1B). This domain con-
sists of three signature motifs, namely (1) the phosphate
binding loop (GxxxxGK(S/T)), (2) the switch II region
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(DXXG), and (3) the guanine recognition loop (NKxD)
[36].
This domain has been investigated biochemically in the
case of the R1.LlaJI homologue, the McrB subunit of the
McrBC endonuclease – and has revealed interesting varia-
tions from the archetypal GTPase family (see discussion)
[29].
Additional conserved modules (of identity) can be dis-
cerned within R1.LlaJI and its homologues; however, at
this point no functional significance can be assigned to
any of these regions (Fig 1B). It was suggested for McrB,
that some of these conserved modules, at the time identi-
fied using completely different protein sets, may contrib-
ute in some manner to the diverged functionality of the
GTP-binding domain [29]. Hence, it is likely that, as for
McrB, R1.LlaJI represents yet another member of a distinct
subclass of the classical GTPase family.
For most of the identified R1.LlaJI homologues, signifi-
cant alignment was only achieved with portions of the
sequences corresponding to the C-terminal half of each,
with the N-terminal portions apparently representing
non-conserved sequence. The two exceptions to this,
namely LlaIB and BsuMIB (Fig 1A and 1B), which are
A: LlaJI and its identified homologous restriction modification systemsFigure 1
A: LlaJI and its identified homologous restriction modification systems. Genes sharing protein sequence homology to LlaJI com-
ponents are linked by shading (with the percentages representative of the respective identity to LlaJI). B: Alignment of R1.LlaJI 
with is identified homologues. The aligned regions correspond to a section containing the three conserved motif's (indicated 
above each on the alignment) which comprise the predicted GTP binding and hydrolysis domain. Motif II for McrB is under-
lined. Additional conserved modules in this region are indicated by dashed lines above each. C: Alignment of the section of 
R2.LlaJI and its identified homologues predicted to contain the catalytic centre. The conserved PD...Xn....(D/E)XK motif is indi-
cated.
LlaJI, Lactococcus lactis plasmid 
pNP40 [1]. 
Helicobacter pylori J99 chromosome 
(Mcr homologue) [5].
Streptococcus pyogenes MGAS10394 
chromosome [6] 
LlaI, Lactococcus lactis
plasmid pTR2030 [3]. 
BsuMI, Bacillus subtilis 168 
chromosome [2] 
Bacillus cereus 14579 
chromosome [4] 
- - - - - - L Y G V P G A G K S F T I E H - E Y I N E - - G S P - - R E R L V F H P D Y T R1.LlaJ (269-439)
I S R N R I V Y G A P G T G K S Y K L N K - D A K E F F P D D D - L Y I R V T L Y P N Y S R1.Bce14579 (269-458)
I - - - - I L Y G V P G S G K S Y T L Q R - D Y C N N - - - S V - - V E K I V F H P D Y S R1.jhp0164 (154-318)
I - - - - L L Y G V P G S G K S F K I A T - E Y C N D - - E N R - - M E R L V F H P D Y M R1.M6Spy1159 (228-386)
- - - - - - Y Y G A P G T G K S R K V K D - T L L A G V P Q S K - - V F R V T I H P E F T LlaI.2 (7-168)
I P R N R I I Y G A P G T G K S N Y L E R - E V G K I F G D N P Y V F T R V T F F P G Y T BsuMIB (30-220)
L Q - - - - - - G P P G V G K T F V A R R L A Y L L T G E K A P Q R V N M V Q F H Q S Y S McrB (199-353) 
Y S D F V G Q I L P V V T E D N D G N K N - - - - - - - - - - - - - - - - - - V S Y E F T R1.LlaJ (269-439)
Y S Q F V G T Y K P T P I Y K D V E G E - - F Y K S D M V T S I G H G K E P L I D Y T F V R1.Bce14579 (269-458)
Y S D F V G Q I M P S V - - - - D D S G I - - - - - - - - - - - - - - - - - - V S Y K F N R1.jhp0164 (154-318)
N T D F V G Q I M P T V K E N G D - - - - - - - - - - - - - - - - - - - - - - I T Y L F S R1.M6Spy1159 (228-386)
Y S D F I G Q L L P E A T S K G - - - - - - - - - - - - - - - - - - - - - - - V E F K F H LlaI.2 (7-168)
Y G Q F I G A Y K P V P I Y K K L S G E E E I F S S N F R D K M E N F - E P M I D Y Q F V BsuMIB (30-220)
Y E D F I Q G Y R P N G - - - - - - - - - - - - - - - - - - - - - - - - - - - V G F R R K McrB (199-353)
P G P F T T L L K E A Y Y N P K V E H F L V I E E I N R G N A P A I F G E I F Q L L D R K R1.LlaJ (269-439)
P G P F L I Q L V N A L K Y P K S N F V I I I E E I N R A N A A A V F G D V F Q L L D R K R1.Bce14579 (269-458)
P G P F T N I L K K A Y H N P Q T K H V L V I D E I N R G N V P A I F G E I F Q L L D R - R1.jhp0164 (154-318)
P G P F T R I V K K A I D N P S E H Y Y L V I E E L N R G N A P G I F G E I F Q L L D R S R1.M6Spy1159 (228-386)
R G P F T D A L V E A Y A D T S A E V F L V L E E L S R G N V A A I F G D I F Q L L D R - LlaI.2 (7-168)
P G P F I D V L I K A L K N R Y T N F I L I I E E I N R A N A A S V F G D I F Q L L D R N BsuMIB (30-220)
D G I F Y N F C Q Q A K E Q P E K K Y I F I I D E I N R A N L S K V F G E V M M L M E H D McrB (199-353)
I K K N S S S F P I G T S E Y E I S - N T D I A K F V Y N N P - - K H K V H I P S N M S I R1.LlaJ (269-439)
- - - - - - - - D D G E S E Y T I T F N A D V T N Y L R K E G I F D L Q I K I P K N L Y I R1.Bce14579 (269-458)
L K H D K D G F K K G S S E Y A I N - N T D I A N I V H N D K - - N A S I R I P S N L W I R1.jhp0164 (154-318)
- - - - - - - - A S G E S V Y G I N - N S I L A T E I Y G D K - - S H Q I K I P S N L S L R1.M6Spy1159 (228-386)
- - - - - D D Y F V - - S E Y P V N - N K A I A V E L - S Q A - - T D D I K L P S N L N I LlaI.2 (7-168)
- - - - - - - - K N G E S D Y P V T F G P D I M N Y L A R N G I K D E M I K L P S N F F I BsuMIB (30-220)
K R G E N - - - - - - - W S V P L T Y S E N D E E R F Y - - - - - - - - - - V P E N V Y I McrB (199-353)
I G T M N T S D Q N V F T L D T A F Q R R - - W S R1.LlaJ (269-439)
W A T M N S A D Q G V T P L D T A F K R R - - W R1.Bce14579 (269-458)
V A T M N T S D Q N V F T L D T A F Q R R R1.jhp0164 (154-318)
L A T M N T A D Q N V F T L D T A F Q R R R1.M6Spy1159 (228-386)
I G T V N M N D Q N V F P M D T A F K R R F D W K Y LlaI.2 (7-168)
W A T M N N A D Q G V L P L D T A F K R R BsuMIB (30-220)
I G L M N T A D R S L A V V D Y A L R R R F S F I McrB (199-353)
I
II
III
PD-----------------X
n
--------------(D/E)XK      
- - E R M N R P L E P D T I M I Y K D K - - - - V Y V L D A K L Y R - - Y G A M R2.LlaJI (269-320)
Q L I T - K K T F R P D I I K T Y I D I Q R - Y F L I L D A K Y Y N - - I R F K R2.Bce14579 (307-362)
- - Q N P D Y L L Q P D S I M L F D D K - - - - I Y I L D A K Y Y K - - Y G I S R2.jhp0165 (267-317)
- K T S K G Y A L E P D T I M V H N D N - - - - V F V L D A K Y Y K - - F G Q T R2.M6Spy1158 (275-325)
N S L N D S H Y F Q P D Y Y F V D E L R N - - - Q I I F D A K Y Y S K V H G M N LlaIC (305-362)
E V N K E K K T L E P D I I K A F E Y R S K E Y F L I L D A K Y Y N - - I N F D BsuMIC (304-360)
Q S L N L L P R M E T D I T I R S S E K - - - - I L I V D A K Y Y K - - S I F S McrC (233-285)
D V P V A S K L P H S S D I N K Q I T Y R2.LlaJI (269-320)
E - G D L K G N P G V N D I A K Q L L Y E R2.Bce14579 (307-362)
G - - V A S D L P N S A S I I K Q I V Y G R2.jhp0165 (267-317)
N - - L M K D L P P S T S I N K Q I T Y R2.M6Spy1158 (275,325)
Y K Q I C Y N M F L E G Y I G K E Y P D N LlaIC (305-362)
G - K K L E G N P G V E D I T K Q L L Y BsuMIC (304-360)
R - R M G T E K F H S Q N L Y Q L M N Y McrC (233-285)
A. B.
C.
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smaller (337 and 343 aa's, respectively) than R1.LlaJI
(585 aa), aligned completely along the full length of their
respective sequences. Interestingly, both appear to be
encoded by "restriction cassettes" comprised of three
ORF's as opposed to the two observed for the remaining
homologues (Fig 1A).
Database searches with R2.LlaJI (48.8 kDa) revealed a set
of similar proteins that are encoded by genes located adja-
cent to those that had been identified as encoding homo-
logues of R1.LlaJI (see Fig 1A and 1C). 1A multiple
alignment of R2.LlaJI with its homologues allowed the
identification of a putative catalytic centre for DNA cleav-
age; PD...D/ExK. This assignment is supported by inclu-
sion of the McrC subunit of McrBC in the alignment,
whose catalytic centre has essentially been confirmed
[10]. As for R1.LlaJI above, R2.LlaJI shares significant, but
scattered modules of identity with other proteins, but
again the functional significance of this similarity remains
purely speculative.
These data cumulatively suggest that LlaJI, and indeed
other restriction systems exhibit structural and therefore
likely mechanistic similarities with that of the McrBC
methyl-specific endonuclease (see discussion).
Phenotypic and genetic analysis of LlaJI
Previously, we have described the bacteriophage resist-
ance phenotype conferred by the LlaJI operon [1]. To fully
explore the contribution of the individual LlaJI restriction
Table 1: Bacteria, bacteriophage and plasmids used in this study.
Strains and Plasmids Revevant characteristic(s) Reference or source
Strains
E.coli
EC101 Cloning host, KanR. [48]
ER2683 F'proA+B+ lacIq∆ lacZM15 miniTn10 (KanR) fhuA2 ∆(lacI-lacA)200glnV44e14-rfbD1? relA1? 
endA1 spoT1?thi-1 ∆(mcrC-mrr)114::IS10.
NEB collection*
M15 Expression host for pQE 60 derivatives. Qiagen
L.Lactis
MG1614 Plasmid-free derivative of L.Lactis supsp. lactis 712 [49]
NZ9000 MG1363, pepN::nisRK, nisin inducible overexpression host. [42]
NCK690KP1 Partially cured derivative of NCK203. Host strain for phage Ul36 [50]
Bacteriophage
λ E.coli temperate bacteriophage. NEB collection*
Sk1 Small isometric headed phage for MG1614. [51]
C2 Prolate headed phage for MG1614. [52]
Ul36 P335 lytic phage for NCK690 KP1. [53]
Plasmids
pPTPi Low-copy number E.coli-L.Lactis shuttle vector for cloning, TcR. [1]
pJO-J pPTPi derivative containing complete 6.2 kb LlaJI operon from pNP40. [1]
pJO-M1M2 pPTPi derivative containing 3.0 kb fragment from pNP40 encompassing promoter, 
llaJIM1and llaJIM2 genes.
[1]
pNZ8020 High-copy number E.coli-L.Lactis overexpression vector, PnisA, CmR. [54]
pNZ-R1 pNZ8020 derivative containing llaJIR1 under control of PnisA. This study
PNZ-R2 pNZ8020 derivative containing llaJIR2 under control of PnisA. This study
pNZ-R1R12 pNZ8020 derivative containing llaJIR1and llaJIR2 under control of PnisA. This study
pUC19 High-copy number E.coli cloning vector, AmpR. [55]
pUC-R1 pUC19 derivative containing llaJIR1. This study
pUC-R2 pUC19 derivative containing llaJIR2. This study
pUC-R1R2 pUC19 derivative containing llaJIR1 and llaJIR2. This study
pMal-c2x Medium-copy number expression plasmid NEB collection*
pMal-R2 pMal-c2x derivative containing llaJIR2. This study
pQE60 High-number 6xhis tag expression plasmid. Qiagen
pQE-R1 pQE60 derivative containing llaJIR1. This study
pQE-R2 pQE60 derivative containing llaJIR2. This study
pRep4 Low-copy number LacI expressing pQE60 companion Qiagen
plasmid.
* New England Biolabs collection, obtained from M. Sibley and E. Raleigh at NEB.
BMC Microbiology 2006, 6:40 http://www.biomedcentral.com/1471-2180/6/40
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"subunits" to this phage resistance activity, we adopted a
genetic subcloning approach. To this end, the llaJIR1 and
llaJIR2 genes were amplified individually, and in tandem,
and placed under the control of the strong nisin-inducible
promoter of plasmid pNZ8020 to facilitate their over-
expression.
The resulting constructs, pNZ-R1, pNZ-R2, and pNZ-R1R2
were subsequently introduced into the expression host
NZ9000, containing the plasmid pJO-M1M2 (which
encodes both LlaJI MTases), and analyzed for their ability
to confer phage resistance. As can be seen from Table 2, it
was apparent that both R1.LlaJI and R2.LlaJI were
required for the complete LlaJI phenotype (an observa-
tion we had previously alluded to [1]). Furthermore, at
30°C the degree of phage resistance exhibited by the host
over-expressing both LlaJI subunits (on plasmid pNZ-
R1R2) was 100-fold greater than that exhibited by the
"wild type" LlaJI operon present on the low copy number
plasmid pJO-J. Notably, the significant decrease in EOP
conferred by the host containing pJO-J, which accompa-
nied growth at 19°C, the previously established optimum
for LlaJI-mediated resistance, was not preserved in the
pNZ-R1R2 containing host. In fact, at 30°C the degree of
LlaJI-mediated resistance conferred by pNZ-R1R2 was
comparable to that obtained at 19°C with the pJO-J con-
taining host, which would suggest that the upper thresh-
old for LlaJI activity had been reached.
The fact that this optimal level of resistance may be
achieved at 30°C by mere over-expression of R1.LlaJI and
R2.LlaJI suggests that the temperature sensitivity of the
LlaJI system previously reported, may be attributable to
the intracellular concentration of active LlaJI at the respec-
tive temperatures (modulated by the LlaJI natural tran-
scriptional signals), rather than to the temperature
"activity" spectrum of assembled functional LlaJI, as had
previously been speculated [1].
As stated, the results obtained with the hosts expressing
R1.LlaJI and R2.LlaJI individually (on plasmids pNZ-R1,
and pNZ-R2, respectively) indicated that neither subunit
alone was capable of restricting the growth of phage.
However, despite the lack of significant decrease in EOP at
either sampling temperature used, a delicate but visibly
obvious variable plaque phenotype was observed for the
host expressing R1.LlaJI alone (see Table 2). Perhaps most
intriguing was the complete absence of any detectable
endonuclease activity in crude extracts of lactococcal
strains containing either pJO-J or the pNZ-R1R2 over-
expression plasmid (which as stated was always accompa-
nied with plasmid pJO-M1M2).
Purification of the individual LlaJI subunits
As it was established that both LlaJI subunits were
required for "complete" activity, it was assumed that
expression of the individual subunits separately for purifi-
cation purposes could be achieved in the absence of the
LlaJI MTases. To this end, both llaJIR1 and llaJIR2 were
cloned in plasmid pQE60 to produce derivatives pQE-R1
and pQE-R2, respectively which were subsequently estab-
lished in E.coli (see materials and methods). Over-expres-
sion with pQE-R1 allowed purification of R1.LlaJI as a C-
terminal 6xhis tagged derivative. Mass spectrometry and
N-terminal sequencing confirmed the predicted molecu-
lar mass (68.139 kDa inclusive of the mass of the 6x His
tag) and identity of purified R1.LlaJI.
Purification of R2.LlaJI by this approach failed, possibly
due to instability of the resulting recombinant protein. To
overcome this presumed instability, llaJIR2 was inserted
downstream of the malE gene of plasmid pMal-c2x under
the control of the Ptac promoter (see materials and meth-
ods) which, upon induction resulted in the expression of
an R2-MBP fusion of the predicted molecular mass (~90.8
kDa). This fusion was purified by affinity chromatography
using amylose resin and the R2.LlaJI subunit was subse-
quently released from the R2-MBP preparation by cleav-
Table 2: LlaJI mediated bacteriophage resistance to the lactococcal phage Sk1.
Strain/plasmid 30°C 19°C
EOP Plaque size after 16 hrs 
(mm)
EOP Plaque size after 16 hrs 
(mm)
MG1614/pPTPi 1 3 1 2–3
MG1614/pJO-J 3.3 × 10-3 3 2.6 × 10-6 1–2
NZ9000/pJO-M1M2/
pNZ8020
1 3 1 2–3
NZ9000/pJO-M1M2/pNZ-
R1
0.7–1 3 0.5–1 1–2 and pinpoint
NZ9000/pJO-M1M2/pNZ-
R2
1 1 1 2–3
NZ9000/pJO-M1M2/pNZ-
R1R2
1 × 10-5 2–3 5 × 10-6 1–2 and pinpoint
BMC Microbiology 2006, 6:40 http://www.biomedcentral.com/1471-2180/6/40
Page 6 of 12
(page number not for citation purposes)
age with factor Xa protease. Rebinding of MBP to amylose
resin resulted in purification of R2.LlaJI to ~60 % homo-
geneity.
Assignment of the specificity determining LlaJI subunit
Given the domain architecture shared between R1.LlaJI
and McrB, and the established DNA binding activity of the
latter, we investigated the possibility of R1.LlaJI constitut-
ing the DNA recognition element of LlaJI.
Mobility shift assays were therefore performed with
R1.LlaJI using probes containing both single and multiple
LlaJI sites, in addition to a non-specific probe (see materi-
als and methods, and Figure 2A). As can be seen from Fig-
ure 2B, an obvious and specific DNA binding activity was
evident using probes J1 and J2, each containing a single
LlaJI recognition site. For both probes, binding did not
result in a defined shifted band (with the R1.LlaJI concen-
trations used), but rather appeared as a "strewn" binding
pattern, suggestive of a poorly defined protein:DNA stoi-
chiometry of the retarded complex. At high R1.LlaJI con-
centrations, binding to probe J (which contained two LlaJI
sites) resulted in the formation of more apparent yet still
"diffuse" and extremely slow migrating complexes (Fig.
2B), reminiscent of the high molecular weight complexes
formed by McrB with its specific probe [34]. Incubation of
probe J3 (which is devoid of LlaJI sites) with excess
R1.LlaJI did not reveal any binding activity (Fig 2B), and
this finding, combined with competition experiments
with unlabelled "specific" probes confirmed the specifi-
A: Schematic representation of the 230 bp DNA probes used for mobility shift assaysFigur  2
A: Schematic representation of the 230 bp DNA probes used for mobility shift assays. The positions of the intact LlaJI recogni-
tion sequences are indicated. B: Mobility shift assay with specific and non-specific probes (as indicated) which were incubated 
with increasing concentrations of purified R1.LlaJI. Final concentrations of protein are specified above each lane. C: Mobility 
shift assay with probe J which was incubated with increasing concentrations of purified R1.LlaJI (as indicated above each lane). 
The presence (+) or absence (-) of 5 mM GTP/ATP is as specified.
5’ 3’
GACGC
CTGCG
GCGTC
CGCAG
5’ 3’
5’ 3’
5’ 3’
J  :
J1 :
J2 :
J3 :
0       0.05  0.125  0.250 0.375    1         0      1.5      0 1        1.5       0       1        1.5Final protein conc. (µM) :
Probe : J J3 J1 J2
0       0.25    0.5     1        0      0.25    0.5      1      0      0.25    0.5      1Final protein conc. (µM) :
- + GTP +ATP
A. B.
C.
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city of the observed interactions (data not shown). Inclu-
sion of Mg+2 in the binding buffer had no discernable
effect on R1.LlaJI specific binding, nor did its addition
post protein:DNA complex formation. Interestingly how-
ever, and in contrast to McrB, inclusion of GTP did not
stimulate the R1.LlaJI DNA interaction (Fig 2C). In fact it
appeared that GTP, and to a lesser extent ATP, had a very
modest inhibitory effect on the observed binding activity.
A similar analysis using partially purified R2.LlaJI did not
reveal any DNA binding to the LlaJI site containing
probes. In addition, R2.LlaJI did not appear to have any
discernable effect on the R1.LlaJI binding activity.
Investigation of the biological activity of the purified LlaJI 
subunits
As mentioned above, it was not possible to detect specific
endonuclease activity in crude cell extracts of lactococcal
strains (over)expressing the LlaJI system (as measured by
its phage resistance phenotype). Subsequent attempts to
reconstitute active LlaJI by combination of the partially
purified subunits in various ratios, and with an assort-
ment of cofactors (see materials and methods) failed to
reveal any specific nuclease activity. Furthermore, neither
subunit was found to exhibit a DNA nicking activity. Pos-
sible explanations for these observations are discussed
below.
The presence of the putative GTPase domain in R1.LlaJI
prompted us to investigate whether or not this subunit
displayed such an activity. Analysis of GTP hydrolysis,
conducted by colorimetric assay (see materials and meth-
ods) suggested that R1.LlaJI did not exhibit an intrinsic
GTPase activity. Surprisingly, R1.LlaJI dependent GTP
hydrolysis could not be activated by the inclusion of
"specifc" DNA and/or partially purified R2.LlaJI in the
reaction. Similar results were obtained with alternative
nucleotides.
Phenotypic analysis of heterologous LlaJI expression
In an attempt to explain the lack of endonuclease activity
in the protein preparations, a phenotypic investigation of
the efficacy of LlaJI in the heterologous E. coli host was
performed. As can be seen from Table 3, no significant
resistance to bacteriophage proliferation was observed
with a host containing plasmid pJO-J, encoding the com-
plete LlaJI system. A similar phenotype was associated
with the host over-expressing R1.LlaJI or R2.LlaJI alone
(plasmids pUC-R1 and pUC-R2, respectively).
When both subunits were over-expressed in the same host
(plasmid pUC-R1R2) however, and in agreement with
results for the lactococcal over-expression host above, a
phage resistance phenotype was apparent (Table 3). The
degree of this resistance was significantly lower than
expected given the number of LlaJI sites on the λ genome
and the obvious relationship between EOP and LlaJI site
frequency for the lactococcal phage used (see Table 4).
The lack of phage resistance associated with the pJO-J con-
taining host was therefore likely attributable to the lower
copy number of this replicon, coupled to the lower effi-
ciency of in vivo LlaJI restriction in this host.
Investigation of the temperature induced efficacy of LlaJI
in E.coli further revealed that, although the observed
resistance (with plasmid pUC-R1R2 at 30°C) was not evi-
dent at 37°C, it was not significantly enhanced with
growth at low temperatures (data not shown). Again, as
with the lactococcal hosts, crude extracts of E.coli over-
expressing R1.LlaJI and R2.LlaJI (from plasmid pUC-
R1R2) did not exhibit detectable endonuclease activity.
Discussion
The molecular mechanism by which the lactococcal plas-
mid-encoded LlaJI R/M system achieves DNA restriction
has remained largely elusive. Previous studies have char-
acterized the phage resistance capabilities of this four-
gene cluster which is accompanied by an intricate tran-
scriptional regulatory mechanism [1,20].
Table 3: LlaJI-mediated resistance to bacteriophage λ. Results 
reflect values obtained for assays conducted at 30°C.
Strain/plasmid EOP
ER2683/pPTPi 1
ER2683/pJO-J 1
ER2683/pJO-M1M2/pUC19 1
ER2683/pJO-M1M2/pUC-R1 1
ER2683/pJO-M1M2/pUC-R2 1
ER2683/pJO-M1M2/pUC-R1R2 7 × 10-2
Table 4: Relationship between EOP and frequency of LlaJI recognition sites on selected phage genomes.
Phage EOP Genome size (kb) No. LlaJI sites
Sk1 3.3 × 10-3 28.4 10
C2 1 × 10-4 22.1 32
UL36 3 × 10-2 36.8 7
Lambda 7 × 10-2 48.5 102
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In the present study we offer additional phenotypic and
genetic data which alludes to an unusual mode of action
for LlaJI. Analysis of the deduced amino acid sequence for
R1.LlaJI revealed a segmented architecture, with a C-ter-
minally located putative GTP binding and hydrolysis
domain, and a largely unique N-terminal portion. This
organization was similar to that observed for the McrB
subunit of the McrBC methyl-specific endonuclease
[25,37].
A mutational analysis of the three motifs which comprise
the GTPase domain of McrB confirmed the assignment for
motif I only, which is the most highly conserved of the
three with respect to R1.LlaJI and its homologues (see Fig
1B). Conservative substitutions in motifs II and III failed
to unequivocally confirm the proposed assignments on
McrB [29]. It was suggested that the proposed motif III,
although essential for GTP binding and hydrolysis (N333
in particular), rather than define nucleotide specificity
(predicted for D336), was more likely to be involved in
McrC interaction (a suggestion corroborated by the signif-
icant McrC-stimulated GTPase activity of McrB) [29]. The
apparent replacement of the conserved lysine of motif III
with a threonine (a divergence also preserved on R1.LlaJI,
Fig1A) further substantiated the likelihood of this motif
contributing an atypical function.
In addition, the relative spacing between motif's II and III
on McrB (29 amino acids), appeared too short to be struc-
turally analogous to the classical GTPases (>49 amino
acids)[29,38]. However, in the case of R1.LlaJI, the spac-
ing between these proposed motifs is, although relatively
large, more canonical (112 amino acids), and in fact the
alignment reveals an alternative candidate for the McrB
motif II (although the conserved glycine would be
replaced by glutamine, Fig 1B).
It has been shown that it is the N-terminal 160 amino
acids of McrB which, like R1.LlaJI did not exhibit signifi-
cant homology to the database, specified the DNA bind-
ing activity of McrBC [37]. This, in addition to the
placement of the GTPase domain suggested that an equiv-
alent activity could be attributable to the unique N-termi-
nal portion of R1.LlaJI. We examined these predicted
properties for R1.LlaJI and indeed established a specific
DNA binding activity for this subunit to LlaJI-site contain-
ing DNA fragments.
Interestingly, and in contrast to McrB, R1.LlaJI did not
exhibit an intrinsic GTPase activity, which could neither
be stimulated by specific DNA nor partially purified
R2.LlaJI. This latter finding was again in contrast to McrB,
whose intrinsic GTPase activity was stimulated 30-fold by
McrC [28]. A putative catalytic centre was identified
within the amino acid sequence for R2.LlaJI, which sug-
gested a role for this subunit in substrate strand hydroly-
sis; however, neither R2.LlaJI nor R1.LlaJI (and
combinations of the two) exhibited cleavage or nicking
activity.
The absolute requirement for both R1.LlaJI and R2.LlaJI
for complete in vivo activity was clearly demonstrated
(Table 2). A mild phenotype was associated with over-
expression of R1.LlaJI alone (in Lactococcus), although this
was most likely due to DNA binding only, which may
have served to partially hinder the phage replication
machinery.
Although less dramatic, heterologous expression of
R1.LlaJI and R2.LlaJI in E.coli provided resistance to phage
infection where, again an absolute requirement for both
R1.LlaJI and R2.LlaJI was observed (Table 3). The relative
poor efficacy of the resistance provided in this host back-
ground was attributed to instability of the R2.LlaJI subu-
nit. This subunit, in contrast to R1.LlaJI, could not be
observed in over-expressing cell extracts when analyzed by
SDS-PAGE.
Purification of R2.LlaJI was only achieved when stabilized
by fusion to a carrier protein. It is possible that in this
fusion correct folding of the R2.LlaJI subunit had been
inhibited, and was not subsequently corrected following
the proteolytic removal of the carrier. This could account
for our inability to reconstitute an active endonucleolytic
complex with R1.LlaJI despite the clearly evident DNA
binding activity of the latter.
Furthermore, it is possible that the predicted GTP hydro-
lyzing activity (which presumably facilitates DNA translo-
cation) of R1.LlaJI would only become apparent
following assembly of the "active" heterooligomer on its
target DNA. It must be noted however, that an additional
lactococcal derived cofactor, proteinacious or otherwise,
can not be entirely excluded at this point, despite the
absence of endonuclease activity in LlaJI-expressing lacto-
coccal crude extracts.
In summary, LlaJI is a heterooligomeric endonuclease
wherein the R1.LlaJI subunit is responsible for determin-
ing specificity. It is suggested that R2.LlaJI harbours the
catalytic centre for DNA cleavage, whose site, although
undetermined, is likely to be defined by the relative
"placement" of R2.LlaJI on the target DNA (due to its pro-
posed interaction with R1.LlaJI).
Conclusion
LlaJI was shown to retain behavioral characteristics of a
conventional Type IIA system, in that unmethylated DNA
is targeted in vivo however; unlike any characterized
enzyme of its kind it exhibits striking genetic similarities
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with the Type IV enzyme McrBC, which is specific for
methylated DNA. The presence of an McrBC-like enzyme
as a component of an R/M system suggests two mutually
exclusive modes of action for these enzyme types whereby
they are either in isolation, cleaving methylated DNA
(McrBC), or in combination with MTases cleaving
unmethylated DNA (LlaJI). Whilst unusual, this is not
altogether surprising as such contrasting activities have
been described for some conventional endonucleases
(DpnI and DpnII) [39,40]. Similarly organized R/M sys-
tems were found in the database and together with LlaJI,
are likely to represent a new subgroup of the Type II fam-
ily, combining features of both Type II and Type IV sys-
tems. Further biochemical characterization of LlaJI, and
indeed its identified and relatively unknown homologues
(Fig 1A) will hopefully disclose further revelations regard-
ing this novel and remarkable endonuclease family.
Methods
Bacteria, bacteriophage, plasmids, media and growth 
conditions
Details of bacterial strains, bacteriophage and plasmids
used in this study are summarized in Table 1. All L. lactis
strains were grown in M17 broth (Oxoid ltd., Hampshire,
UK) containing 0.5 % glucose at 30°C. E. coli was grown
at 37°C in Luria-Bertani media [41]. Where appropriate,
antibiotics were added as follows: for L. lactis, 5 µg ml-1
tetracycline, and 10 µg ml-1 chloramphenicol. For E. coli,
100 µg ml-1 ampicilin, 25 µg ml-1kanamycin and 10 µg
ml-1 chloramphenicol. Induction of the nisin-inducible
promoter of pNZ8020 in the NZ9000 host background
was achieved by inclusion of nisin (1 ng ml-1) in growth
media [42]. Induction of Ptac, T5, and Plac promoters of
pMal-c2x, pQE60, and pUC19, respectively, was achieved
by inclusion of 1 mM IPTG in growth media of their
respective E.coli hosts. Lactococcal bacteriophage were
propagated as described previously [1]. Plaque assays
were conducted as described elsewhere [43] and the effi-
ciency of plaquing (EOP) was calculated as the ratio of the
number of plaques formed on a tested host to those
formed on a sensitive host. Bacteriophage λ.0 was propa-
gated and enumerated using standard techniques [41].
Molecular techniques
Restriction enzymes and T4 DNA ligase were purchased
from New England Biolabs (Hertfordshire, UK), and used
according to the manufacturer's instructions. E.coli plas-
mid DNA was isolated using the SV wizard plasmid mini-
prep kit (Promega, Madison, WI, USA) according to the
manufacturer's instructions. Lactococcal plasmid DNA
was isolated as described previously [44]. Electroporation
of plasmid DNA into E.coli was performed using standard
techniques [41] and in L. lactis as described previously
[45]. For routine PCR applications Taq DNA polymerase
(Qiagen, West Sussex, UK.) was used. For plasmid con-
struction, where high fidelity was required, PCR's were
conducted using Phusion DNA polymerase (New England
Biolabs) according to the manufacturer's instructions. All
PCR products were purified using the Jetquick PCR purifi-
cation kit (Genomed, Lohne, Germany). The correct ori-
entation and integrity of all constructs was verified by
sequencing, performed at MWG Biotech (Ebersberg, Ger-
many). Sequence assembly, verification and analysis were
achieved using the seqman program from the DNASTAR
package (DNASTAR, Madison, WI.). Database searches
were performed using the BLAST suite of programs [46]
and the REBASE database [7]. The nucleotide sequence of
the LlaJI system is present in the GenBank database; acces-
sion no. AY530537.
Plasmid constructs
For the construction of plasmid pNZ-R1, an llaJIR1
encompassing PCR product (coordinates 2999–4782,
using primers R1F 5'gggggatcccatataggaggacaaaataatg'3
and R1R 5'gggctcgagccatcctctattcttcagtg'3) was inserted
into the BamHI – XhoI sites of pNZ8020. Plasmid pNZ-
R2 was constructed by insertion of an llaJIR2 encompass-
ing PCR product (coordinates 4769–6031, using primers
R2F 5'gggggatccgaatagaggatggctctatg'3 and R2R 5'gggctc-
gagctaggaattcgggtattctat'3) into the BamHI – XhoI sites of
pNZ8020. Similarly, for plasmid pNZ-R1R2, an llaJIR1R2
encompassing PCR product (coordinates 2999–6031,
using primers R1F and R2R) was inserted into the BamHI
– XhoI sites of pNZ8020.
For plasmid pQE-R1, an llaJIR1 encompassing PCR prod-
uct (coordinates 3017–4772, using primers R1QEF
5'gggccatgggaaaaatcgtattacca'3 and R1QER 5'gggagatctttct-
tcagtgctaacattatc'3) was inserted into the NcoI – BglII sites
of pQE60. For plasmid pQE-R2, an llaJIR2 encompassing
PCR product (coordinates 4786–6031, using primers
R2QEF 5'gggccatggaaactaacaaaactattaa'3 and
R2QER5'gggagatctggaattcgggtattctattg) was inserted into
the NcoI – BglII sites of pQE60. Plasmid pMal-R2 was
constructed by insertion of an llaJIR2 encompassing PCR
product (coordinates 4786–6031 using primers MalR2F
5'atggaaactaacaaaactattaa'3 and MalR2R 5'gggtctagactag-
gaattcgggtattcta'3) into the XmnI – XbaI sites of pMal-c2x.
Plasmid pUC-R1 was constructed by insertion of an
llaJIR1 encompassing PCR product (coordinates 3003–
4775, using primers UCR1F 5'gggggtcgacttaaggag-
gacaaaataatgggaa'3 and UCR1R 5'gggggatccctattcttcagt-
gctaacatta'3) into the SalI – BamHI site of pUC19. For
plasmid pUC-R2, an llaJIR2 encompassing PCR product
(coordinates 4773–6031, using primers UCR2F 5'
gggggtcgacttaagaggatggctctatggaaa'3 and UCR2R
5'ggggaatccctaggaattcgggtattctat'3) was inserted into the
SalI – BamHI sites of pUC19. Plasmid pUC-R1R1 was
constructed by insertion of an llaJIR1R2 encompassing
PCR product (coordinates 3003–6031, using primers
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UCR1F and UCR2R) into the SalI – BamHI sites of
pUC19.
Protein expression and purification
R1.LlaJI was expressed as a C-terminal 6xhis tagged deriv-
ative, overproduced from plasmid pQE-R1 in the M15/
pRep4 host background and purified essentially to homo-
geneity using Ni-NTA Agarose (Qiagen) affinity chroma-
tography, according to the manufacturer's instructions.
R2.LlaJI was overproduced from plasmid pMal-R2 in
ER2683 and purified by affinity chromatography using
amlyose resin (New England Biolabs), according to the
manufacturer's instructions. Purified proteins were subse-
quently dialyzed against buffer containing 10 mM Tris
(pH 7.5), 50 mM KCl, 1 mM DTT, 0.1 mM EDTA and 50
% glycerol, and stored at -20°C. Initial mass and purity
estimations were achieved by SDS-PAGE [47] under dena-
turing conditions. Mass spectrometry and N-terminal
amino acid sequencing where indicated was performed at
the University of Newcastle Upon Tyne using an Applied
Biosystems Voyager DESTR mass spectrometer and a Beck-
man LF 3000 microsequencer.
Gel mobility shift analysis
DNA binding assays were carried out in 20 µl volumes
containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 5
mM β-mercaptoethanol, 8 % glycerol and 50 µg ml-1 calf
thymus DNA and approximately 2.5–5 nM final concen-
tration of a probe. All probes were generated by PCR
amplification of a section of the LlaJI promoter (coordi-
nates 309–539 using primers akjF 5'ctggagactatattgct-
catcg'3 and P1R 5'gggattgtgtttgaaatcacacc'3) which
contained two LlaJI recognition sites. Probe J represented
the "wild type" sequence. Disruption of the 5' proximal
and 3'proximal sites individually (by C-A replacement of
the internal cytosine of 5'GCGTC'3) to produce probes J1
and J2 respectively, was achieved by oligonucleotide-
directed mutagenesis. Both sites were disrupted in this
manner to produce probe J3, which was devoid of any
LlaJI recognition sites. All probes were subsequently end-
labelled with (γ-32P)ATP by use of polynucleotide kinase
(New England Biolabs). Binding reactions were allowed
to proceed at room temperature for 30 minutes, followed
by the addition of 5 µl 50 % glycerol. Samples were then
subjected to electrophoresis on a 4 % polyacrylamide gel
containing 2.5 % glycerol in 1 × TAE buffer for 3 hours at
120 V. The protein-DNA complexes were detected by
autoradiography of the dried gel.
DNA Cleavage assays
Crude cell extracts of L. lactis strains were prepared from 1
l of culture grown in GM17 broth, concentrated by centrif-
ugation (7000 rpm, 15 min) and washed in lysis buffer
(10 mM Tris-HCl (pH 7.6), 1 mM EDTA, 100 mM NaCl
and 1 mM DTT). The cell pellets were resuspended in 10
ml of lysis buffer and disrupted with a French press (at
2000 lb/in2) after which cell debris and ribosomes were
removed by centrifugation (14,000 rpm, 20 min). E. coli
crude extracts were generated essentially as above from 1 l
of culture grown in LB broth, where lysis was achieved by
sonication (5 × 10 sec bursts punctuated by 30 sec on ice).
Cleavage activity of LlaJI was surveyed in all 4 NEBuffers
(New England Biolabs) and at temperatures ranging from
19 – 30°C.
Typically the reactions contained 1 µg substrate DNA (λ
DNA and Sk1 DNA for cleavage assays or pBR322 DNA
for nicking assays), 100 µg ml-1 BSA, and 2 µl crude extract
in addition to 5 mM GTP in a final volume of 20 µl. For
assays with purified proteins, typically reactions con-
tained 0.5 µg R1.LlaJI or R2.LlaJI (or combinations of the
two at ratios of 5:1, 2:1, 1:1, 1:2, 1:5, R1.LlaJI:R2.LlaJI).
GTPase assays
GTP hydrolysis activity of R1.LlaJI was investigated via
quantification of the release of inorganic phosphate by
colorimetric assay based on spectrophotometric quantifi-
cation of a phosphomolybdate-malachite green complex
using the Malachite Green Phosphate Assay kit (Bioassay
Systems, Hayward, CA 94545, USA) according to the
manufacturer's instructions.
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